Published in Cardiovascular Device Liability Week, January 2nd, 2005
According to a study from Germany, "In pharmacological bioassays on isolated ring-shaped auricle preparations of Sepia officinalis, the action of the specific 5-hydroxytryptamine (5-HT) agonists 8-OH-DPAT (5-HT1a ), CP-93129 (5-HT1b ), TFMPP (5-HT1b ) and RS-67333 (5-HT4 ) on these autonomously contractile compartments was studied."
T. Lehr and colleagues reported, "8-OH-DPAT and CP-93129 induced mainly...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.